Skip to main content
UTIUniversal Technical Institute ISell4.0·$38.48-10.42%
Open full analysis

Universal Technical Institute I (UTI) Stock Analysis

Breakout setup

SellVALUE-TRAP 2/5Moderate Confidence

Consumer Defensive · Education & Training Services

Sell if holding. Analyst target reached at $38.48 — A.R:R is negative (-0.3) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Regulatory: Title IV Programs and veterans' programs (78.0%).

Universal Technical Institute operates two post-secondary education divisions: UTI (15 campuses for transportation/skilled trades/energy) and Concorde Career Colleges (17 campuses for healthcare programs) serving students nationwide. Revenue comes from student tuition funded... Read more

$38.48+16.0% A.UpsideScore 4.0/10#15 of 15 Education & Training Services
QualityF-score6 / 9FCF yield1.14%
Stop $35.95Target $44.83(resistance)A.R:R -0.3:1
Analyst target$42.50+10.4%6 analysts
$44.83our TP
$38.48price
$42.50mean
$49

Sell if holding. Analyst target reached at $38.48 — A.R:R is negative (-0.3) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Regulatory: Title IV Programs and veterans' programs (78.0%). Chart setup: Golden cross, above all MAs, RSI 56, MACD bullish. Score 4.0/10, moderate confidence.

Passes 5/7 gates (clean insider activity, no SEC red flags, earnings proximity 57d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Aug 5, 202657d to earnings· next earnings call

Thesis

Rewards
Sector modifier (Consumer Defensive): +0.8
Strong earnings beat streak (3/4)
Risks
Concentration risk — Regulatory: Title IV Programs and veterans' programs (78.0%)
Analyst target reached - limited upside remaining
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4)

Key Metrics

P/E (TTM)56.5
P/E (Fwd)46.2
Mkt Cap$2.4B
EV/EBITDA28.0
Profit Mgn4.9%
ROE13.5%
Rev Growth6.7%
Beta1.25
DividendNone
Rating analysts11

Quality Signals

Piotroski F6/9MoatNarrow

Options Flow

P/C0.74neutral
IV60%elevated
Max Pain$18-54.5% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHregulatoryTitle IV Programs and veterans' programs78%
    10-K Item 1A: 'including Title IV Programs and veterans’ programs, from which we derived approximately 78% of our revenues, on a cash basis, in fiscal 2025'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
0.0
Revenue Growth
4.2

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
1.4
Quality Rank
3.5
Growth Rank
4.7

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ev Ebitda
0.0
Pe
2.2
Forward Pe
2.5
Peg Ratio
3.5
Analyst Target
4.0
Ps
8.5
Forward P/E: 46.2xPEG: 3.34
GatesMomentum 4.2<4.5A.R:R -0.3=NEGATIVEInsider activity: OKNo SEC red flagsEARNINGS PROXIMITY 57d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
56 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $35.70Resistance $45.74

Price Targets

$36
$45
A.Upside+16.5%
A.R:R-0.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Target reached (-4.4% upside)
! momentum at 4.2 (below the engine's 4.5 threshold)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-08-05 (57d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is UTI stock a buy right now?

Sell if holding. Analyst target reached at $38.48 — A.R:R is negative (-0.3) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Regulatory: Title IV Programs and veterans' programs (78.0%). Chart setup: Golden cross, above all MAs, RSI 56, MACD bullish. Prior stop was $35.95. Score 4.0/10, moderate confidence.

What is the UTI stock price target?

Take-profit target: $44.83 (+16.0% upside). Prior stop was $35.95. Stop-loss: $35.95.

What are the risks of investing in UTI?

Concentration risk — Regulatory: Title IV Programs and veterans' programs (78.0%); Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.4).

Is UTI overvalued or undervalued?

Universal Technical Institute I trades at a P/E of 56.5 (forward 46.2). TrendMatrix value score: 3.4/10. Verdict: Sell.

What do analysts say about UTI?

11 analysts cover UTI with a consensus score of 4.1/5. Average price target: $43.

What does Universal Technical Institute I do?Universal Technical Institute operates two post-secondary education divisions: UTI (15 campuses for...

Universal Technical Institute operates two post-secondary education divisions: UTI (15 campuses for transportation/skilled trades/energy) and Concorde Career Colleges (17 campuses for healthcare programs) serving students nationwide. Revenue comes from student tuition funded predominantly by Title IV Programs and veterans' benefits, which together represented ~78% of fiscal 2025 cash revenues.

Related stocks: TAL (TAL Education Group) · EDU (New Oriental Education & Techno) · PRDO (Perdoceo Education Corporation) · LAUR (Laureate Education, Inc.) · LOPE (Grand Canyon Education, Inc.)
Home Stocks UTI

Latest news

Latest News

Benzinga6d agoCONCERNEarnings
MarketBeat47d agoEarnings
MarketBeat48d ago
Investing.com40d agoEarnings
Investing.com40d ago
Seeking Alpha40d agoEarnings
TipRanks40d agoEarnings
TipRanks40d ago
Quiver Quantitative40d ago
Kens5.com40d agoEarnings
Marketscreener.com40d agoEarnings
HarianBasis.co48d ago
Insider Monkey48d ago
Investing.com South Africa41d agoEarnings
Investing.com41d agoEarnings
StockStory42d agoEarnings
Yahoo Finance46d ago
Marketscreener.com46d agoAnalyst
Yahoo Finance47d ago
MarketBeat40d agoEarnings
Loading more...